PI3Kα inhibitor DFX24 shows antiproliferation and apoptosis of lung cancer cells by inhibiting PI3K/AKT and ERK but promoting EPH receptor B6 (EPHB6) expression [141]. Here, MAPK1 is linked to lung cancer.